既往血管腔内治疗失败的CLTI患者:开放旁路与腔内治疗的比较
基于VQI数据库2016-2023年53,793例CLTI患者,比较既往旁路或腔内治疗后再行血运重建的结局。既往旁路组中,再次旁路与腔内治疗的一年结局无显著差异;既往腔内治疗组中,开放旁路与较低死亡、再干预和MALE/死亡风险相关。
要点
- 既往旁路术后再血运重建,旁路与腔内治疗一年结局无显著差异。
- 既往腔内治疗失败后,开放旁路较再次腔内治疗的一年死亡和再干预风险更低。
- 既往腔内治疗组中,开放旁路与更好的无MALE生存相关。
核心结论
- 既往下肢旁路术后再血运重建的结局与手术方式无关。
- 既往腔内治疗后再血运重建,开放旁路较再次腔内治疗的一年死亡、再干预和MALE/死亡风险更低。
研究设计与样本
- 回顾性队列研究,查询Vascular Quality Initiative数据库2016-2023年CLTI患者。
- 纳入既往下肢旁路或腔内治疗后再行腹股沟下开放或腔内血运重建者,排除同侧大截肢或同期手术。
- 采用倾向性评分匹配(1:1)生成匹配队列:既往旁路组1,047对,既往腔内治疗组5,603对。
主要发现
- 既往旁路组匹配后,旁路与腔内治疗的一年死亡、大截肢、再干预和MALE均无显著差异。
临床怎么用
- 对既往旁路术后再发CLTI,旁路与腔内治疗均可选择,需个体化决策。
- 对既往腔内治疗后再发CLTI,开放旁路可能带来更优的一年死亡和再干预结局。
局限性
- 为回顾性数据库研究,可能存在选择偏倚和未测量混杂。
- 仅分析一年结局,缺乏长期随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Open bypass with single segment great saphenous vein is the optimum procedure for chronic limb-threatening ischemia (CLTI). However, many CLTI patients require revascularization after a prior failed lower extremity bypass or endovascular therapy (ET). Hence in this study, we aimed to investigate outcomes of bypass vs ET in patients with prior bypass as well as in those with prior ET. METHODS: The Vascular Quality Initiative database was queried for CLTI patients who underwent infrainguinal open or endovascular revascularization after a prior lower extremity bypass or ET from 2016 to 2023. Patients with prior ipsilateral major amputation (MA), or concomitant procedures were excluded. Two well matched (SD<0.1) propensity score-matched (PSM) cohorts (1:1) were produced for patients who underwent 1-prior bypass and 2-prior ET. Cox regression, Kaplan Meier survival analysis, and Log Rank test were used to analyze one-year outcomes of bypass vs ET in both groups. Outcomes include mortality, MA, reintervention, and major adverse limb events [MALE (reintervention or MA)]. RESULTS: A total of 53,793 patients were included. In the group with prior bypass, 3499 (60%) underwent ET and 2338 (40%) had another bypass. While in the prior ET group, 39,738 (82.9%) had another ET and 8218 (17.1%) had a bypass. PSM produced two well matched cohorts in each group [prior bypass 1047 pairs; prior ET 5603 pairs]. After matching, there was no significant difference in any of the outcomes between bypass and ET after a prior bypass. There was a trend of lower one-year mortality with bypass after a prior bypass (HR, 0.79; 95% CI, 0.61-1.03; P = .078]. However, in patients with prior ET, bypass was associated with lower hazard of mortality (HR, 0.82; 95% CI, 0.73-0.91; P < .001), reintervention (HR, 0.73; 95% CI, 0.63-0.83; P < .001), and MALE/death (HR, 0.91; 95% CI, 0.84-0.98; P = .015] at one year compared with ET. CONCLUSIONS: This real-world multi-institutional study revealed that outcomes of revascularization after a prior lower extremity bypass are not associated with procedure type. However, in patients with prior ET, open lower extremity bypass is associated with lower hazard of mortality and reintervention as well as better MALE-free survival compared with secondary endovascular intervention.
引用
- Hamouda M, Zarrintan S, Straus S, et al. Open bypass versus endovascular therapy in chronic limb-threatening ischemia patients with prior endovascular attempts. J Vasc Surg. 2026. PMID: 41512936. doi:10.1016/j.jvs.2025.12.350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。